Home | Publications | Diagnostics place holder
place holder place holder

Diagnostics

Blood Banking and Blood products


Publication Date   March 2008
Publisher   Global Industry Analysts
Product Type   Report
Pages   641
ISBN Number   not applicable
Product Code   GIA004
Ask a question about this product?

Price £1,995.00

approximately: $3,523 | €2,530

Summary


This report analyzes the worldwide markets for Blood Banking & Blood Products in Millions of US$. The specific product segments analyzed are Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis).

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest ofWorld . Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for thesemarkets with annual market analytics. The report profiles 144 companies including many key and niche players worldwide such as:

America’s Blood Centers, AABB, American Red Cross, CorCell Inc., Japan Red Cross, LifeBank Cryogenics, National Blood Foundation, New England Cord Blood Bank, Inc., New York Blood Center, The Cord Blood Registry, VITA 34 AG, Beckman Coulter Inc, Becton Dickinson, Bio Products Laboratory, Chiron Corporation, CSL Behring, Daxor Corporation, Fresenius Group, Gambro BCT, Gen-Probe Incorporated, Grifols, Haemonetics, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and ZymeQuest, Inc.Market data and analytics are derived from primary and secondary research.
Please note that company profiles are mostly extracted from URL research and reported select online sources.

Content



  • I. Introduction, Methodology & Product Definitions


    • Study Reliability and Reporting Limitations

    • Disclaimers

    • Data Interpretation & Reporting Level

    • Quantitative Techniques & Analytics

    • Product Definitions and Scope of Study

    • Blood Components and Plasma Products

    • Whole Blood & Cellular Components

    • WBCs

    • RBCs

    • Platelets

    • Plasma Fractions

    • Fresh Frozen Plasma

    • Albumin Fractions

    • Factor VIII

    • Factor IX and Factor IX Complex

    • Fibrin/Thrombin

    • Equipment, Blood Tests and Consumables

    • Automated Analyzers for Blood Analysis

    • Blood Tests

    • Consumables




  • II. Executive Summary


    • 1. Market Overview


      • Healthcare Scares Propel the Market

      • Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts

      • Worldwide Blood Banking and Blood Products Market at a Glance

      • Current & Future Analysis

      • Analysis by Geographic Region

      • Analysis by Product Segment

      • World Blood Components and Plasma Market Analysis in Units

      • Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 2: World 10-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World for Years 2001, 2006 & 2010 (includes corresponding Graph/Chart)

      • Red Blood Cells - A Key Blood Component and a Major Contributor

      • Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 4: World 10-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World for Years 2001, 2006 & 2010 (includes corresponding Graph/Chart)




    • 2. Market Trends & Issues


      • New Infections - A Continuous Threat

      • Safety and Availability: The Core Issues

      • Decontamination: A Viable Process

      • New Processes for Safer Blood Supply

      • Innovative Procedures Help Blood Conservation

      • Autologous Transfusion Strapping up for High Growth

      • Enzyme Converted Cells Set to Rule the Industry

      • Blood Unavailability: Substitutes to the Rescue

      • Transfusions: Hospitals Making Way for Others

      • Computer Identification Helps Patients

      • SARS: A Case of Mistaken Identity?

      • Pooling: Economical HIV Testing

      • Private Cord Blood Banking: Flying High Despite Opposition

      • Automation of Blood Banking - Nearing the Efficiency Frontier?

      • Automated Instrumentation Taking the Front Seat

      • Table 5: World Market for Blood Bank Technology (2004): Percentage Value Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage and Pathogen Inactivation (includes corresponding Graph/Chart)

      • Table 6: World Market for Automated Collection of Blood Components using Apheresis Technology (2005): Percentage Breakdown by Revenues for Gambro, Baxter, Haemonetics, Fresenius and Others (includes corresponding Graph/Chart)

      • Plasma Market: Automation Making Inroads

      • The RBC Market - Slow to Catch Up

      • Automation of Testing - Yet to Mature

      • Automation to Suffice Shortage Problems

      • How Near to the Efficiency Frontier?




    • 3. Product Overview


      • Blood Banking and Blood Products Industry

      • Blood Components and Plasma Products

      • Equipment, Blood Tests and Consumables

      • Automated Analyzers for Blood Analysis

      • Blood Tests

      • Consumables

      • Blood - A Primer

      • Ionic Structure

      • Blood Components and their Applications

      • Blood Constituents

      • Plasma

      • Table 7: World Recent Past, Current & Future Analysis for Plasma Products - Annual Sales in US$ Million for Years 2003 through 2010 (includes corresponding Graph/Chart)

      • Red Blood Cells (RBC)

      • Blood Count

      • Platelets

      • White Blood Cells (WBC)

      • Derivative Products of Blood or Plasma Fractions

      • Plasma Protein and Fractionation

      • The Need

      • Fresh Frozen Plasma

      • Other Plasma Fractions

      • Albumin Fractions

      • Albumin Usage Rising in Profile, Wastage Worries Run Deep

      • Factor VIII

      • Factor IX and Factor IX Complex

      • Fibrin/Thrombin

      • Consumption of Blood Based on Type of Surgery/ Accident (In Units)

      • Table 8: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Region for US, Europe, Asia-Pacific, Latin America and Rest of World (includes corresponding Graph/Chart)

      • Table 9: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Product for IVIG, Factor VIII, Albumin, Alpha-1, Fibrin, Factor IX, AT III and Others (includes corresponding Graph/Chart)




    • 4. Blood Collection Methods


      • Banking the Natural Blood Resources

      • Blood Banks

      • Blood Banking

      • Blood Transfusion

      • Role of Blood Banks

      • Blood Donor: The Epicenter of the Process

      • Eligibility Criteria for the Donor

      • The Basics of Blood Donation - Myths Exploded & Other Facts

      • Collection Methods

      • Blood Donation: The Process

      • Types of Blood Donation

      • Directed Blood Donations

      • Autologous Blood Donation

      • Alternative Usage of Patient's Own Blood

      • General Blood Donation

      • Hemodilution

      • Wound Drainage

      • Cell Saver

      • The Method

      • Blood Salvaging

      • Blood Collection Centers

      • Blood Collection Management System

      • A Historical Retrospective

      • Blood Collection Centers

      • Types of Blood Collection Centers

      • Cord Blood Banks

      • Profit Collection Centers

      • Military Blood Banks

      • Hospital Blood Banks

      • Community Blood Banks

      • Non-Profit Collection Centers

      • Blood Processing

      • Blood Typing

      • Rh Blood Group System

      • ABO Blood Group System

      • Blood Types and their Compatibility

      • Table 10: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)

      • Blood Test

      • Blood Culture

      • The Costs




    • 5. The Changing Landscape of Transfusion Technologies & Tests


      • Blood Transfusion: A Backdrop

      • Massive Transfusion

      • Complications and Risks Due to Transfusion

      • Circulatory Overload

      • Graft Versus Host Disease (GVHD)

      • Haemolytic Transfusion Reactions

      • Iron Overload

      • Bacterial Contamination

      • Thrombophlebitis

      • Allergic Reactions

      • Air Embolism

      • Hyperkalaemia

      • Changing Role of Blood Banking Technology




    • 6. Blood Transfusion: The Process, Tests/Technologies


      • Cross Matching

      • Blood Donor/Recipient Screening

      • Blood Typing

      • Leukoreduction

      • Leukocyte Reduction Specification Standards/Filters

      • Coombs Test




    • 7. Alternatives to Blood Transfusion: A Real Threat to the Industry


      • Bloodless Surgery

      • Therapeutic Apheresis

      • Plasmapheresis

      • Plateletpheresis

      • Leukapheresis

      • Volume Expanders

      • Colloids

      • Albumin

      • Dextrans

      • Hydroxyethyl Starch

      • Crystalloids

      • Blood Growth Factor Therapies - Newer Alternatives to Transfusion




    • 8. Blood Substitutes


      • Blood Substitutes Under Development by Manufacturers

      • Pipeline Update for Blood Substitutes & Alternatives

      • Synthetic Blood International's Oxycyte™ Undergoes Phase II Clinical Trial

      • Maelor's Volplex Sets Foot into the Brazilian Market

      • BioTime's Hextend Receives Marketing Approval in Korea

      • Alliance Inks Licensing Deals to Market OXYGENT™

      • Gelatin-based Adhesives to Seal Growth of Blood Products

      • BioTime's Hetacool Wins Major Research Grants from NIH

      • Sangart's Hemospan™ Wins New Grant Funding for Phase II Trial

      • Synthetic Blood Manufacturers/Developers

      • Alliance Pharmaceuticals Corp. (USA)

      • Biopure Corporation (USA)

      • Enzon Pharmaceuticals (USA)

      • Hemosol Inc. (Canada)

      • Northfield Laboratories Inc. (USA)

      • Sangart Inc. (USA)

      • SONUS Pharmaceuticals, Inc. (USA)

      • Synthetic Blood International, Inc. (USA)




    • 9. Product Introductions/Innovations


      • Dade Behring Launches the Quadriga BeFree System

      • Swedish Inventors Develop New Processing System

      • Canada Invents New Method for Monitoring Blood and Blood Products

      • Terumo Launches Improvised Bags For Safe Blood Collection

      • Haemonetics Launches Cymbal Automated Blood Collection System

      • Illinois Inventors Introduces New Systems to Prepare Blood Products

      • Abbott Unveils Two New Products for Blood Banks

      • Cell Robotics Introduces New Lasette P 200

      • Beckman's COULTER® LH 750 Hematology Analyzers Hit the Market

      • Haemonetics Unveils MCS®+ - Improved Red Cell Collection Technology

      • Baxter Launches ALYX Component Collection System

      • Grifols' DG Gel® Revolutionizes Column Agglutination




    • 10. Product Introductions/Innovations in the Recent Past


      • BioMérieux Introduces DAVINCI®

      • Pall Develops Novel Blood Filtration Membrane

      • Hemotech Launches Blood Recycling Product

      • Greiner North America Innovates MiniCollect Tubes

      • BioLargo Rolls out BI2O-Sorb

      • Terumo Penpol Introduces Terumo Automatic Component Extractor

      • BD Obtains FDA Approval for New Blood Collection Kit

      • Horiba Introduces Compact Blood Component Analyzer

      • PreAnalytiX Introduces PAXgene System

      • HemaMetrics Releases Crit-Scan

      • Pall Unveils Filter Products




    • 11. Products in Pipeline & Technology Update


      • From Clinical Trials to Clinics

      • Zyme Quest's ECO Cells Set to Spike the Blood Supplies Worldwide

      • Cerus Receives CE Mark Approval for the Intercept Blood System for Platelets

      • Haemonetics Wins FDA Approval for the ACP 215 System

      • Biomerieux' Polycarbonate BacT/ALERT Receives US FDA Clearance

      • Pall's eBDS Receives Green Signal from FDA

      • CardioPAT™ Surgical Blood Salvage System Gearing up for A Launch

      • PCS® 2 - Set to Enhance Plasma Quality

      • Dade Behring's D-Dimer Assay Strapping up for Roll Out

      • Waiting for Regulatory Go Ahead

      • Leukotrap from Pall - A vCJD Prion Filter

      • ThermoGenesis' DAC - A Non Contact Blood Separator

      • Under Trial

      • Procleix® Tigris™ Improves Ultrio's HIV, HCV and HBV Detection Time by 42%

      • Akers' ANC Rapid Tests Accorded Priority Status

      • Navigant Biotechnologies Gets Additional $2 Million Funding From US DOD

      • Potential Applications Unravel

      • Cord Blood Provides New Solutions for Leukemia

      • Pluristem Upgrades Cord Blood Hematopoietic Stem Cells




    • 12. Recent Industry Activity


      • SunTech Medical Group Acquires Empirical Technologies

      • Cord Blood America Acquires Cryobank

      • Cord Blood Acquires CorCell

      • Kalbe Acquires Stake in CyGenics's Subsidiary CordLife Indonesia

      • Haemonetics to Take Over Arryx

      • Cryobanks International Signs Letters of Intent with MedStem Services

      • Cryobanks International Opens Cord Blood Stem Cell Bank

      • DomaniCell Initiates Family Cord Blood Banking Program in Hospitals

      • Cryobanks International Grants License for Cord Blood Processing System

      • Baxter to Sell Transfusion Therapies to an Investment Group

      • Community Blood Center Bags Contract

      • Wilkes Medical Center Grants License for SafeTrace Tx

      • Biosite Collaborates with HUG Research Hospital

      • Pliva Terminates Agreement with Mayne

      • Mississippi Blood Services Secures Contract

      • APL Partners with Omscan

      • DomaniCell Receives Stem Cell Banking License

      • ThermoGenesis Enters into an Agreement with Cord Blood Registry

      • ZLB Enters into Plasma Deal with BCA

      • ViaCell and Pall Secure FDA Approval for ViaCord® Collection Kit

      • Pall Secures Contract from NBS to Supply 'Leukotrap' Filtration System

      • Biotest and Sanquin to Form Joint Venture for Plasma Production

      • Consorta Signs Partnership Agreement with GSABC

      • Haemonetics Signs Supply Agreement with Canadian Blood Services

      • Haemonetics Extends the Agreement with American Red Cross

      • Novation and Abbott Enter into a Technology Agreement

      • Olympus Redefines the Agreement with Biotest

      • Cerus to Receive Marketing Rights over Baxter's INTERCEPT Blood System

      • CyGenics to Establish a New Cord Blood Banking Company

      • UKCBB to Establish a Modern Laboratory in UMIC's New CTF

      • St. John's Medical Center Procures Wyndgate's SafeTrace Tx

      • Florida`s Blood Centers Acquires South Florida Blood Banks

      • BioStem Takes Over Cryobanks International

      • FCBS Creates a Niche for itself by designing Cord Blood Stem Cells and Offers Public Donation Option

      • Pall Signs Sale Agreement with Green Cross for Blood Filters

      • TCBB Starts Collecting Donations for Cord Blood

      • Pall Received FDA Clearance to Market New Pall Acrodose™ PL System

      • CordLife Singapore Receives AABB Accreditation

      • ITL and ARC Enter into an Agreement for Blood Bank Equipment

      • NBA and UKT Merge to Form NHSBT

      • BioMérieux and ExonHit Extend Collaboration to Develop Blood Diagnostics

      • Wyndgate Signs Agreement with Cameron Hospital

      • Daxor's Subsidiary Wins Corporate Blood Banking Contract from Taglich Brothers

      • Baxter and American Red Cross Enter Into Agreement

      • CSL Signs Agreement with National Blood Authority

      • Chiron Finds a South African Partner for Procleix® Tigris®

      • ThermoGenesis and BHHTI Jointly Market CryoSeal FS

      • Baxter and Cerus Enter into a Marketing Agreement

      • Haemonetics Signs Technology Alliance with ZLB Plasma Services

      • BioTime Collaborates with Summit Pharmaceuticals International Corp

      • SurgiLance Bags a Contract from America's Blood Centers

      • Florida's Blood Centers Acquire Lake Park-based South Florida Blood Banks

      • Global Med Technologies' Division Signs Agreement with Hospital Partners of America

      • Radiometer America and Consorta Extend Blood-Gas Products Deal

      • Baxter's ALYX System Wins Medical Design Excellence Award

      • Terumo Corp. Ups Stake in Blood Bag Venture

      • Vita 34 International AG Takes over the Holdings of Corcell and Vita 34

      • CSL Acquires Aventis Behring

      • Medsurge Medical Products Corp. Buys Cryo Genomics

      • Haemonetics' Acquisition of Harvest Technologies Expands Surgical Blood Salvage Portfolio

      • Chiron Buys out Prion Solutions

      • Celmed & Gambro Tie up for GvHD Prevention System

      • Chiron Grants NAT Licenses to LabCorp and German Red Cross

      • Sekisui Chemical Ventures into Chinese Blood Collection Market

      • Stratec and Biotest Partner on the Development of a Blood Grouping Analyzer

      • PRDT, ARC & Maco Pharma in a Strategic Alliance

      • Pall's Enhanced Bacterial Detection System to be Marketed by Kawasumi

      • Baxter and Cerus Rope in Bioone Corp for Marketing Intercept

      • Chiron Partners with ZymeQuest

      • Pall Corporation Signs Agreement with Haemonetics Corporation

      • Immucor Set to Unfurl Galileo's Potential Across World

      • Haemonetics Corporation & Hemosystem SA in a Marketing Alliance

      • Chiron's Armor Strengthened with Infectio's Rapid Bacterial Detection Licenses

      • Haemonetics, Braemed and Caster in a Marketing Agreement for Cell Saver® 5

      • Haemonetics Obtains Marketing Licenses for Crit Scan®

      • Lifebank Receives AABB Accreditation

      • Bayer Divests Plasma Products Business to NPS

      • ITL Receives FDA Clearance to Market SSK

      • ThermoGenesis' DAC System Awaits FDA Approval

      • Chronix Biomedical Files Patent Approval for a New Diagnostic Test

      • ViaCell's Selective Amplification™ Program Boosts Cord Blood Banks' Productivity

      • CordLife Opens Second Cord Blood Banking Facility Singapore

      • PharmaStem Inks Multiple Licensing Deals for Cord blood Preservation Technologies

      • Novation Bags Big Ticket Deals for Blood Products




    • 13. Strategic Corporate Developments in the Recent Past


      • Lifebank Signs Agreement with JGH

      • Pall Obtains FDA Approval for DONOR™ Blood Reinfusion System

      • Pall Receives FDA Approval to Sell New Blood Collection Product

      • Chiron Boosts Presence in Asia

      • New England Cord Blood Bank Starts Two Laboratories in Venezuela and Mexico

      • OGA, FemPartners and Viacord Proffer Umbilical Cord Blood Services

      • ZLB Bioplasma Buys Nabi's Testing Laboratory and Antibody Collection Centers

      • Interaqua Acquires Imunna

      • Drew Scientific Purchases MWI

      • Formosa and Yung Shin Ink a Joint Venture Deal

      • Cordlife and Shenyang Xiehe Establish CordLife Xiehe

      • Altachem and Erdos-Cashmere Form Beijing Erdos Altachem Pharma Ltd

      • Pall Signs Development and Licensing Agreement with Viragen

      • Chiron Signs Licensing Agreement with Roche

      • Indian Government Makes Testing for Hepatitis C Virus in Blood Banks Obligatory

      • Biopool Merges with Xtrana Inc

      • V.I Technologies Extends Transfusion Plasma Contract with ANRC

      • New England Cord Blood Bank Commences Operations of a Cord Blood Bank in the UK

      • Bergen Brunswig Launches Pharmabid.com, an Auction Website for Blood Products




    • 14. Focus on Select Global Players


      • Leading Blood Banks

      • America's Blood Centers (US)

      • AABB (US)

      • American Red Cross (US)

      • Blood Bank of Alaska (US)

      • California Cryobank (US)

      • Children's World Blood Bank (US)

      • Community Blood Bank (US)

      • CorCell Inc. (US)

      • Indian Red Cross Society (India)

      • Japan Red Cross (Japan)

      • LifeBank Cryogenics (Canada)

      • National Blood Foundation (US)

      • New England Cord Blood Bank, Inc. (US)

      • New York Blood Center (US)

      • Oklahoma Blood Institute (US)

      • Rajkot Voluntary Blood Bank (India)

      • The Cord Blood Registry (US)

      • Thomas Jefferson University Hospital Blood Bank (US)

      • VITA 34 AG (Germany)

      • Leading Players in Blood Bank Technology and Supplies

      • Baxter International Inc. (US)

      • Beckman Coulter Inc (US)

      • Becton Dickinson (US)

      • BioMérieux SA (France)

      • Chiron Corporation (US)

      • Chiron Blood Testing (US)

      • Daxor Corporation (US)

      • Fresenius Group (Germany)

      • Gambro (Sweden)

      • Gen-Probe Incorporated (US)

      • Global Med Technologies, Inc. (US)

      • Haemonetics (US)

      • Hemagen Diagnostics Inc. (US)

      • Immucor Inc. (US)

      • Innovative Technologies for Life Limited (Australia)

      • Kawasumi Laboratories, Inc. (Japan)

      • Lifebank Cryogenics Corp. (Canada)

      • Novation LLC (US)

      • Olympus America, Inc. (US)

      • Pall Corp (US)

      • Pathogen Removal and Diagnostic Technologies, Inc. (US)

      • PharmaStem Therapeutics, Inc. (US)

      • Radiometer America, Inc. (US)

      • Surgical Innovation Group Plc (UK)

      • Terumo (Japan)

      • ThermoGenesis Corp. (US)

      • ViaCell, Inc. (US)

      • ZLB Behring L.L.C. (US)

      • ZymeQuest, Inc. (USA)




    • 15. Global Market Perspective


      • Table 11: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 12: World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

      • Table 13: World 20-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

      • Table 14: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 15: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 16: World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

      • Table 17: World Historic Review for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

      • Table 18: World 20-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

      • Table 19: World 20-Year Perspective for Blood Components and Plasma Products by Product Group - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 1991, 1995, 2006 & 2010

      • Table 20: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 21: World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

      • Table 22: World 20-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

      • Table 23: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 24: World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

      • Table 25: World 20-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

      • Table 26: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 27: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

      • Table 28: World 20-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)







  • III. Market


    • 1. The United States

    • A. Market Analysis


      • Current and Future Analysis

      • Historic Review

      • Key Trends/Facts

      • US Blood Collection & Supply Profile

      • Blood Group Distribution

      • Table 29: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart)

      • Table 30: Percentage Break up of Rh Blood Types in the US by Racial Group

      • Blood Donated and Transfused Every Year

      • Males Form the Major Chunk of Donors

      • Declining Donor Population

      • Cost of Blood

      • SARS Scares: Blood Banks Feel the Heat

      • Whole Human Blood: Export-Import Scenario in the Recent Past

      • Table 31: US Market for Whole Human Blood (2003 & 2004): Percentage Volume & Value Breakdown of Export by Country for France, Canada, United Kingdom, Germany, Japan, Taiwan, Korea, Belgium, The Netherlands, Italy, Peru, and Others (includes corresponding Graph/Chart)

      • Table 32: US Market for Whole Human Blood (2003 & 2004): Percentage Volume & Value Breakdown of Import for Consumption by Country for Japan, United Kingdom, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)

      • US Blood Components and Plasma Market Analysis in Units

      • Table 33: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 34: US 10-Year Perspective for Blood Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2001, 2006 & 2010 (includes corresponding Graph/Chart)

      • Product Introductions/Innovations

      • Product Introductions/Innovations in the Recent Past

      • Recent Industry Activity

      • Strategic Corporate Developments in the Recent Past

      • Focus on Select Players

      • Blood Banks

      • Blood Bank Technology Developers and Consumables Suppliers




    • B. Market Analytics


      • Table 35: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

      • Table 36: US Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

      • Table 37: US 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)




    • 2. Canada


      • A. Market Analysis


        • Current and Future Analysis

        • Historic Review

        • The 'CSA-Z902-04' - A New Comprehensive Voluntary Blood Safety Standard

        • LifeBank Cryogenics - The Only AABB Accredited Cord blood Stem Cell Bank

        • Recent Industry Activity

        • Strategic Corporate Developments in the Recent Past

        • Product Innovation

        • Product Introduction in the Recent Past

        • Lifebank Cryogenics Corp. - A Key Player




      • B. Market Analytics


        • Table 38: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 40: Canadian 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)







    • 3. Japan


      • A. Market Analysis


        • Un Upwardly Spiraling Market for FFP

        • Current and Future Analysis

        • Historic Review

        • Product Launch

        • Product Introduction in the Recent Past

        • Recent Industry Activity

        • Focus on Select Players




      • B. Market Analytics


        • Table 41: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 42: Japanese Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 43: Japanese 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)







    • 4. Europe


      • A. Market Analysis


        • Current & Future Analysis

        • Analysis by Geographic Region

        • European Blood Banking and Blood Products Market at a Glance (All figures are 2004 estimates & CAGR is for the period 2001-2010)

        • Analysis by Product Segment

        • Historic Review

        • Analysis by Geographic Region

        • Analysis by Product Segment

        • Industry Trends and Issues

        • Legislations on Payment for Donation Restrict Donors

        • Lack of Proper Facilities Hamper Production of Plasma Products

        • Government's Check on Healthcare Costs Pressurizes BCT Manufacturers

        • Grim Scenario for Manufacturers as Purchasing System Witnesses Modifications

        • EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products

        • Factors Driving the Market

        • Cautious Mood of Customers Drives Blood Collection Devices Market

        • Elders Remain Primary Demand Drivers

        • Innovative Technologies on the Horizon

        • New EU Implementations Spell Opportunity for Blood Banking Industry

        • Factors Restraining the Market

        • Innovative Surgical Processes Put Blood Loss and Blood Replacement to a Minimum

        • Blood Substitutes - Industry's Answer to Supply Shortages

        • A Snapshot of Health Care Systems Across Select EU Countries

        • France

        • Germany

        • Italy

        • The UK

        • Spain

        • Product Introductions/Innovations

        • Recent Industry Activity

        • Focus on Select Players

        • BioMérieux SA (France)

        • Fresenius Group (Germany)

        • Gambro (Sweden)

        • Surgical Innovation Group Plc (UK)




      • B. Market Analytics


        • Table 44: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 45: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 46: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 47: European Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 48: European 20-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)

        • Table 49: European 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)




      • 4a. France


        • A. Market Analysis

        • Current and Future Analysis

        • Competitive Scenario in the Recent Past

        • Table 50: Leading Players in the French Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown by Revenues for Kedrion, Baxter, and Others (includes corresponding Graph/Chart)

        • Historic Review

        • B. Market Analytics

        • Table 51: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 52: French Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 53: French 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)




      • 4b. Germany


        • A. Market Analysis

        • Current and Future Analysis

        • Competitive Scenario in the Recent Past

        • Table 54: Leading Players in the German Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown by Revenues for ZLB Behring, Baxter, Bayer and Others (includes corresponding Graph/Chart)

        • Historic Review

        • B. Market Analytics

        • Table 55: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 56: German Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 57: German 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)




      • 4c. Italy


        • A. Market Analysis

        • Current and Future Analysis

        • Historic Review

        • B. Market Analytics

        • Table 58: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 59: Italian Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 60: Italian 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)




      • 4d. United Kingdom


        • A. Market Analysis

        • Current and Future Analysis

        • Competitive Scenario in the Recent Past

        • Table 61: Leading Players in the UK Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown by Revenues for Bio Products Laboratory, Baxter, Grifols and Others (includes corresponding Graph/Chart)

        • Historic Review

        • B. Market Analytics

        • Table 62: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 63: UK Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 64: UK 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)




      • 4e. Spain


        • A. Market Analysis

        • Current and Future Analysis

        • Competitive Scenario in the Recent Past

        • Table 65: Leading Players in the Spanish Blood Banking Devices and Plasma Products Market (2003 & 2004) - Percentage Breakdown by Revenues for Baxter, Grifols, ZLB Behring and Others (includes corresponding Graph/Chart)

        • Historic Review

        • Strategic Development in the Recent Past

        • B. Market Analytics

        • Table 66: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 67: Spanish Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 68: Spanish 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)




      • 4f. Russia


        • A. Market Analysis

        • Current and Future Analysis

        • Historic Review

        • B. Market Analytics

        • Table 69: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 70: Russian Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 71: Russian 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)




      • 4g. Rest of Europe


        • A. Market Analysis

        • Current and Future Analysis

        • Historic Review

        • Developments in Recent Past

        • B. Market Analytics

        • Table 72: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 73: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 74: Rest of Europe 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)







    • 5. Asia-Pacific


      • A. Market Analysis


        • Current and Future Analysis

        • Historic Review

        • ASEAN - Striding Towards Standardization of Blood Supply

        • China -A Key Market

        • Government Wakes Up to Realities

        • Table 75: Chinese Market for Blood Banking and Blood Products: Percentage Share Breakdown by Type of Blood Groups (includes corresponding Graph/Chart)

        • Table 76: Chinese Market for Blood Banking and Blood Products: Percentage Share Breakdown of Blood Donor by Gender

        • Table 77: Chinese Blood Banking and Blood Products Market: Percentage Share Breakdown of Blood Donor by Age Group (includes corresponding Graph/Chart)

        • Recent Industry Activity

        • Strategic Corporate Developments in the Recent Past

        • Product Introduction in Recent Past

        • Focus on Select Players

        • Indian Red Cross Society (India)

        • Rajkot Voluntary Blood Bank (India)




      • B. Market Analytics


        • Table 78: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 79: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 80: Asia-Pacific 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)







    • 6. Latin America


      • A. Market Analysis


        • Current and Future Analysis

        • Historic Review




      • B. Market Analytics


        • Table 81: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 82: Latin American Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 83: Latin American 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)







    • 7. Rest of World


      • A. Market Analysis


        • Current and Future Analysis

        • Historic Review




      • B. Market Analytics


        • Table 84: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

        • Table 85: Rest of World Historic Review for Blood Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

        • Table 86: Rest of World 20-Year Perspective for Blood Banking and Blood Products by Product Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions) and Equipment, Blood Tests and Other Consumables for Years 1991, 1995, 2006 & 2010 (includes corresponding Graph/Chart)










  • IV. Competition


    • 1. AABB - American Association Of Blood Banks (USA)

    • 2. Abbott Laboratories (USA)


      • Table 87: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 88: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 89: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 90: Annual Sales Analysis: 2004-2005 (In US$ million)

      • Table 91: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

      • Table 92: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

      • Table 93: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

      • Abbott Diagnostics Division of Abbott Laboratories (USA)




    • 3. Advanced Biotechnologies, Inc. (USA)

    • 4. Advanced Medical Supplies Ltd. (UK)

    • 5. America's Blood Centers (USA)


      • Blood Bank of Alaska (USA)

      • Community Blood Bank (USA)




    • 6. American Red Cross (USA)

    • 7. Analis SA/NV (Belgium)

    • 8. Arkios Biodevelopment International (USA)

    • 9. Baxter International, Inc. (USA)


      • Table 94: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 95: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 96: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 97: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 98: Annual Sales Analysis: 2004-2005 (In US$ million)

      • Table 99: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

      • Table 100: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

      • Table 101: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

      • Baxter Healthcare (Asia) Pte., Ltd. (Singapore)




    • 10. Beckman Coulter, Inc. (USA)


      • Table 102: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 103: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

      • Table 104: Annual Sales Analysis: 2004-2005 (In US$ million)

      • Table 105: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

      • Table 106: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

      • Table 107: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

      • Beckman Coulter GmbH (Germany)




    • 11. Becton Dickinson and Company (USA)


      • Table 108: Annual Sales Analysis: 2004-2006 (In US$ million)

      • Table 109: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

      • Table 110: Annual Sales Analysis by Segment: 2005-2006 (In US$ million)

      • Table 111: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

      • Table 112: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

      • Table 113: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

      • Table 114: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)




    • 12. Beijing Hi-Inc. Health Technology Incubator (China)

    • 13. BelReas Ltd. (Belarus)

    • 14. Bio Products Laboratory (UK)

    • 15. BioCare Corporation (Taiwan)

    • 16. Biocell Laboratories, Inc. (USA)

    • 17. BioMerieux SA (France)


      • Table 115: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In € million)

      • Table 116: Annual Sales Analysis: 2004-2005 (In € million)

      • Advanced Bioscience Laboratories, Inc. (USA)




    • 18. Biopure Corporation (USA)


      • Table 117: Annual Sales Analysis: 2004-2006 (In US$ thousands)

      • Table 118: Annual Sales Analysis by Operation: 2004-2005 (In US$ thousands)

      • Table 119: Annual Sales Analysis by Quarter: 2004-2005 (In US$ thousands)




    • 19. Bio-Rad Laboratories, Inc. (USA)


      • Table 120: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million)

      • Table 121: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million)

      • Table 122: Annual Sales Analysis: 2004-2005 (In US$ million)

      • Table 123: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

      • Table 124: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

      • Table 125: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)




    • 20. Biosystems SA (Spain)

    • 21. Biotec Laboratories Ltd. (UK)

    • 22. Biotest AG (Germany)


      • Biotest Pharma GmbH (Germany)




    • 23. BioTime, Inc. (USA)


      • Table 126: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ thousands)

      • Table 127: Annual Sales Analysis: 2004-2005 (In US$ thousands)

      • Table 128: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ thousands)




    • 24. Blood Bank Of The Redwoods (USA)

    • 25. Borolabs Ltd. (UK)

    • 26. Braemed Ltd. (Canada)

    • 27. California Cryobank (USA)

    • 28. Canadian Blood Services (Canada)

    • 29. Cangene Corporation (Canada)


      • Table 129: First Quarter Sales Analysis: 2006-2007 (In Can$ million)

      • Table 130: Annual Sales Analysis: 2005-2006 (In Can$ million)

      • Table 131: Annual Sales Analysis by Quarter: 2005-2006 (In Can$ million)

      • Table 132: Annual Sales Analysis by Segment: 2005-2006 (In Can$ million)

      • Table 133: Annual Sales Analysis by Geographic Region: 2005-2006 (In Can$ million)




    • 30. Caster Medical Systems (Canada)

    • 31. Cell Robotics International, Inc. (USA)

    • 32. Central Blood Bank (CBB) (USA)

    • 33. Cerus Corporation (USA)